Overview


According to FutureWise analysis, the market for Custom Recombinant Protein Production Services is expected to grow with a CAGR of 11.50% over the forecast period 2024-2032, and reach a market value of US$ 11.7 Billion by 2031. 

Custom recombinant protein production services involve a highly specialized process in the biotechnology and biopharmaceutical industries. This service entails the tailored synthesis of specific proteins using advanced genetic engineering techniques. It begins with isolating and cloning the gene responsible for encoding the desired protein. This gene is inserted into a suitable expression system, commonly a bacterial, yeast, insect, or mammalian cell line. The engineered gene is introduced into the host cells through transformation or transfection, enabling them to produce the target protein. These transformed or transfected cells are then cultivated in controlled environments, allowing for replication and expression of the engineered gene.  The subsequent steps involve purification of the protein from other cellular components, followed by rigorous quality control measures to verify its identity, purity, and functionality. Customization, including modifications or adding specific tags, may be performed to enhance the protein's properties. The process can be scaled up for large-scale production or research-scale applications. The end product is packaged and sent to the client in the chosen format.

Custom recombinant protein production services have diverse applications in drug development, academic research, diagnostics, and industrial processes, enabling the creation of proteins with specific functionalities and structures crucial for scientific advancements and treatments.

FutureWise Market Research has published a report that provides an insightful analysis of Custom Recombinant Protein Production Services Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Custom Recombinant Protein Production Services Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • GenScript Biotech Corporation
  • SignalChem Biotech Inc.
  • Crown Bioscience, Inc.
  • BPS Bioscience Inc.
  • Novoprotein, H
  • Applied Biological Materials (abm) Inc.
  • Eurofins Pharma Discovery Services
  • Abgent (WuXi AppTec Company)
  • OriGene Technologies, Inc.
  • Kempbio, Inc.
  • Trenzyme Gmb
  • Sino Biological Inc.
  • Aragen Bioscience
  • a GVKBIO Company
  • LakePharma, Inc.
  • Proteos Inc.
  • Icosagen AS
  • Novus Biological LLC
  • Proteogenix
  • Premas Biotech
  • ATUM
  • Aldevron

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Custom Recombinant Protein Production Services Market

In July 2021, Atlas Antibodies, a Stockholm-based research antibody provider, revealed its acquisition of Evitria, a biotechnology company. This significant acquisition unites a top-tier supplier of rigorously validated research antibodies with a trailblazer in specialized recombinant antibody expression.

The growing demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and therapeutic proteins, drives the need for custom recombinant protein production services. Ongoing advancements in genetic engineering technologies, such as CRISPR/Cas9 and gene synthesis, are enhancing the efficiency and capabilities of custom protein production services. The substantial investments in research and development activities in the biotechnology and pharmaceutical industries fuel the demand for custom recombinant protein production services. Custom recombinant proteins are essential for personalized medicine approaches, allowing for the developing of tailored therapies for individual patients. Custom recombinant proteins find applications in diverse sectors, including healthcare, agriculture, and industrial processes, contributing to market growth.

However, the production of custom recombinant proteins can be costly due to the increased demand for advanced equipment, skilled personnel, and rigorous quality control processes. Adherence to regulatory guidelines and quality standards for custom protein production can be complex, requiring substantial resources and expertise. Developing and implementing custom protein production services often necessitates specialized knowledge in genetic engineering, molecular biology, and bioprocessing. Some proteins, especially those with complex structures or post-translational modifications, may be challenging to produce using current expression systems and can hamper market growth.

By Expression System

  • Mammalian
  • Bacteria
  • Insect
  • Yeast
  • Others

By End User

  • Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Contract Research Organizations
  • Others

By Region

  • North America
  • Europe
  •  Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the rising trend of crucial market players employing inorganic approaches like acquisitions and partnerships to advance recombinant protein development, which is anticipated to serve as a growth opportunity in the forecast period. A notable example is the strategic partnership agreement between Orthofix US LLC, a medical device company, and CGbio in August 2022. This collaboration aims to develop innovative, synthetic bone grafts for various medical applications, including spine, orthopedic, trauma, and dental.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Custom Recombinant Protein Production Services Market By Expression System, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Custom Recombinant Protein Production Services Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Custom Recombinant Protein Production Services Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Custom Recombinant Protein Production Services Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Custom Recombinant Protein Production Services Market, By Expression System Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Mammalian
      2. Bacteria
      3. Insect
      4. Yeast
      5. Others
  • 8.  Custom Recombinant Protein Production Services Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Research Institutes
      2. Biotechnology and Pharmaceutical Companies
      3. Contract Research Organizations
      4. Others
         
  • 9.  North America Custom Recombinant Protein Production Services Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 10.  Latin America Custom Recombinant Protein Production Services Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 11.  Europe Custom Recombinant Protein Production Services Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 12.  Asia Pacific Custom Recombinant Protein Production Services Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 13.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 14.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 15.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. GenScript Biotech Corporation
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. SignalChem Biotech Inc.
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Crown Bioscience, Inc.
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. BPS Bioscience Inc.
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Novoprotein
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Applied Biological Materials (abm) Inc.
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Eurofins Pharma Discovery Services
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Abgent (WuXi AppTec Company)
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. OriGene Technologies, Inc., 
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Kempbio, Inc.
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Trenzyme Gmb
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Sino Biological Inc., 
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Aragen Bioscience, 
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. a GVKBIO Company
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. LakePharma, Inc.
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview
        16. Proteos Inc.
           16.1. Company Overview
           16.2. Product Portfolio
           16.3. SWOT Analysis
           16.4. Financial Overview
           16.5. Strategic Overview
        17. Icosagen AS
           17.1. Company Overview
           17.2. Product Portfolio
           17.3. SWOT Analysis
           17.4. Financial Overview
           17.5. Strategic Overview
        18. Novus Biological LLC 
           18.1. Company Overview
           18.2. Product Portfolio
           18.3. SWOT Analysis
           18.4. Financial Overview
           18.5. Strategic Overview
        19. Proteogenix
           19.1. Company Overview
           19.2. Product Portfolio
           19.3. SWOT Analysis
           19.4. Financial Overview
           19.5. Strategic Overview
        20. Premas Biotech
           20.1. Company Overview
           20.2. Product Portfolio
           20.3. SWOT Analysis
           20.4. Financial Overview
           20.5. Strategic Overview
        21. ATUM
           21.1. Company Overview
           21.2. Product Portfolio
           21.3. SWOT Analysis
           21.4. Financial Overview
           21.5. Strategic Overview
        22. Aldevron
           22.1. Company Overview
           22.2. Product Portfolio
           22.3. SWOT Analysis
           22.4. Financial Overview
           22.5. Strategic Overview

  • 16.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.  FutureWise SME Key Takeaway Points for Client

    •     


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11